611 N-cbl like
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Homogeneous metal compounds | 8 | 6.8 | 1.18× | q = 0.68 | |
| Phenylpropanoids and polyketides | 1 | 0.3 | 3.48× | not tested | |
| Mixed metal/non-metal compounds | 1 | 0.3 | 3.45× | not tested | |
| Homogeneous non-metal compounds | 5 | 3.0 | 1.68× | not tested | |
| Organoheterocyclic compounds | 3 | 2.1 | 1.41× | not tested | |
| Organic acids and derivatives | 3 | 2.1 | 1.41× | not tested | |
| Benzenoids | 1 | 1.0 | 0.99× | not tested | |
| Organic oxygen compounds | 2 | 2.8 | 0.73× | not tested | |
| Nucleosides, nucleotides, and analogues | 1 | 3.8 | 0.26× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00141 | NAG | N-Acetylglucosamine | 100 |
| DB00142 | GLU | Glutamic acid | 5 |
| DB02999 | QUS | Quisqualic acid | 3 |
| DB04343 | GLV | Glyoxylic acid | 2 |
| DB00128 | ASP | Aspartic acid | 1 |
| DB00134 | MET | Methionine | 1 |
| DB01592 | — | — | 1 |
| DB01833 | GGB | Canavanine | 1 |
| DB03434 | MPO | 3-(N-morpholino)propanesulfonic acid | 1 |
| DB03488 | U2F | Uridine-5'-diphosphate-2-deoxy-2-fluoro-alpha-D-galactose | 1 |
| DB03497 | OSE | L-serine O-sulfate | 1 |
| DB06928 | 24I | (2S)-2-{[HYDROXY(4-IODOBENZYL)PHOSPHORYL]METHYL}PENTANEDIOIC ACID | 1 |
| DB07754 | FBD | DCFBC | 1 |
| DB08835 | — | — | 1 |
| DB14488 | — | — | 1 |
| DB14489 | — | — | 1 |
| DB14490 | — | — | 1 |
| DB14491 | — | — | 1 |
| DB14501 | — | — | 1 |
| DB14520 | — | — | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| NAG | 2-acetamido-2-deoxy-beta-D-glucopyranose | 17 |
| CL | CHLORIDE ION | 15 |
| ZNmetal | ZINC ION | 9 |
| SMmetal | SAMARIUM (III) ION | 8 |
| G88 | (2S)-2-(PHOSPHONOMETHYL)PENTANEDIOIC ACID | 4 |
| GLU | GLUTAMIC ACID | 4 |
| MGmetal | MAGNESIUM ION | 4 |
| CAmetal | CALCIUM ION | 3 |
| QOK | 7-(2-methoxyethoxymethyl)-1,3-dimethyl-purine-2,6-dione | 3 |
| QUS | (S)-2-AMINO-3-(3,5-DIOXO-[1,2,4]OXADIAZOLIDIN-2-YL)-PROPIONIC ACID | 3 |
| A1AEG | (7-methoxy-2-{2-[(1S,3S,4S)-3-(3-methoxy-2-methyl-5-nitrophenyl)-1-methyl-5-oxo-1,5-dihydroimidazo[1,5-a]pyridin-2(3H)-yl]-2-oxoethoxy}quinolin-8-yl)acetic acid | 2 |
| A1IE5 | 2-cyclopropyl-6-methyl-~{N}-[3-[(6~{S})-6-methyl-2-oxidanylidene-1,3-oxazinan-6-yl]phenyl]pyrimidine-4-carboxamide | 2 |
| BIX | (2S)-2-{[(S)-[(3S)-3-amino-3-carboxypropyl](hydroxy)phosphoryl]methyl}pentanedioic acid | 2 |
| BR | BROMIDE ION | 2 |
| GLV | GLYOXYLIC ACID | 2 |
| NImetal | NICKEL (II) ION | 2 |
| PRO | PROLINE | 2 |
| SDR | (2S)-2-[(N-acetyl-L-alpha-aspartyl)amino]nonanoic acid | 2 |
| SY8 | 5-azanylpentan-2-one | 2 |
| Z3N | 2-{3-[(1s,3R)-3-methyl-1-(4-methyl-4H-1,2,4-triazol-3-yl)cyclobutyl]phenyl}-6-{[(3S)-3-methylpiperidin-1-yl]methyl}-4-(trifluoromethyl)-2,3-dihydro-1H-isoindol-1-one | 2 |